Erythromycin A Oxime
|
|
|
- CAS-Nr.
- 111321-02-9
- Englisch Name:
- Erythromycin A Oxime
- Synonyma:
- (9E)-ErythroMycin A OxiMe;Erythromycin A Oxime;(E)-Erythromycin oxime;Erythromycin Impurity J;AzithroMycin iMpurity 20;Azithromycin Impurity 19;Erythromycin Impurity S;Azithromycin impurity 09;Azithromycin CP Impurity S;Erythromycin, 9-oxime, (9E)-
- CBNumber:
- CB51176305
- Summenformel:
- C37H68N2O13
- Molgewicht:
- 748.95
- MOL-Datei:
- 111321-02-9.mol
|
Erythromycin A Oxime Eigenschaften
- Schmelzpunkt:
- 156-166 °C
- Siedepunkt:
- 841.0±65.0 °C(Predicted)
- Dichte
- 1.28±0.1 g/cm3(Predicted)
- storage temp.
- Refrigerator
- Löslichkeit
- Chloroform (Slightly), DMSO (Slightly), Ethanol (Slightly), Methanol (Slightly)
- Aggregatzustand
- Solid
- pka
- 11.96±0.70(Predicted)
- Farbe
- White to Off-White
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
| Bildanzeige (GHS) |
|
| Alarmwort |
|
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H401 |
Toxic to aquatic life |
Hazardous to the aquatic environment, acute hazard |
Category 2 |
|
|
P273, P501 |
| H411 |
Giftig für Wasserorganismen, mit langfristiger Wirkung. |
Langfristig (chronisch) gewässergefährdend |
Kategorie 2 |
|
|
|
|
| Sicherheit |
| P273 |
Freisetzung in die Umwelt vermeiden. |
| P391 |
Verschüttete Mengen aufnehmen. |
| P501 |
Inhalt/Behälter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
Erythromycin A Oxime Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
(9E)-Erythromycin A oxime is a metabolite of the semisynthetic antibiotic roxithromycin .
Chemische Eigenschaften
Off-White Solid
Verwenden
(9E)-Erythromycin A Oxime is a metabolite of Roxithromycin (R700850) in humans. It has anti-Helicobacter pylori activity
Erythromycin A Oxime Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Erythromycin A Oxime Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 96)Lieferanten
- Erythromycin A Oxime
- Erythromycin Impurity J
- (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9
- Azithromycin Impurity S ((9E)-Erythromycin A Oxime)
- (9E)-Erythromycin A Oxime
Roxithromycin EP Impurity C
- Roxithromycin EP Impurity C (Erythromycin Impurity J)
- (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2R,3R,4S,6R)-
4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-
yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-
hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)
oxy)-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyl
oxacyclotetradecan-2-one
- Azithromycin Impurity S(Roxithromycin EP Impurity C)
- (E)-Erythromycin oxime
- Erythromycin Impurity J (Roxithromycin EP Impurity C)
- Roxithromycin EP Impurity C/(9E)-Erythromycin A Oxime/(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethylt
- AzithroMycin iMpurity 20
- (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2R,3R,4S,6R)- 4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2- yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5- hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl) oxy)-10-(hydroxyimino)-3,5
- Azithromycin Impurity 19
- (3R,4S,5S,6R,7R,9R,11S,12S,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9
- (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2R,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9
- Erythromycin, 9-oxime, (9E)-
- Roxithromycin EP Impurity C (Erythromycin A 9-Oxime (E-Isomer))
- (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one
- Azithromycin CP Impurity S
- (9E)-Erythromycin A Oxime,Erythromycin A (E)-9-oxime,Clarithromycin Impurity J(EP),Roxithromycin Impurity C
- (9E)-ErythroMycin A OxiMe
- Erythromycin Impurity S
- (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one (Roxithromycin Impurity)
- Azithromycin impurity 09
- Clarithromycin EP Impurity J(Roxithromycin Impurity C)
- Clarithromycin EP Impurity J(Roxithromycin EP Impurity C)
- 111321-02-9
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Chiral Reagents, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals
